A Cornell-led research team’s improved cell therapy device effectively secreted insulin and controlled blood sugar in diabetic mice for up to six months – showing promise for the possibility of an effective, complication-free treatment ...
Read More
Graduate students and postdoctoral researchers in the Department of Microbiology and Immunology faced stiff competition for this year’s Biocytogen Best Research Paper Award. Their work in infectious disease and host immune responses has been ...
Read More
The discovery of an “Achilles heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult-to-treat disease, researchers have found. ...
Read More
Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine. A study, published Feb. 5 ...
Read More
Much of the three-dimensional architecture of the genome in antibody-producing immune cells is dependent on a gene called SMC3. When this gene is not working properly it can lead to improper immune cell development ...
Read More
The Department of Microbiology and Immunology and the Center for Immunology at Cornell University invite applications from scientists focused on Molecular or Cellular Immunology for multiple tenure-track positions at the Assistant, Associate or Full ...
Read More
As events ignited mainstream awareness and urgency around systemic racism and inequalities, the scientific community has rallied to address systemic bias. Black in Immuno, a movement started by six early-career Black scientists, is mobilizing ...
Read More
A Cornell researcher is studying Nipah virus in an effort to understand the basic mechanisms of transmission and infection, which are necessary steps toward vaccine development and other therapies. Read the full story here.
Dr. Virginia Pascual, the Drukier Director of the Gale and Ira Drukier Institute for Children’s Health at Weill Cornell Medicine, has been awarded a grant supplement from the National Institute of Allergy and Infectious Diseases ...
Read More
T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus’s ...
Read More
